Kobayashi Pharmaceutical Co., Ltd.
Kobayashi Pharmaceutical Co., Ltd. (KBYPF) Revenue
Annual & quarterly revenue history · segment & region breakdown
KBYPF · revenue · updated Jun 9, 2026
Core revenue metrics
Trailing 12 monthsKobayashi Pharmaceutical Co., Ltd. trailing twelve-month (TTM) revenue is $168B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
Compare revenue vs peers
Household & Personal ProductsCompare KBYPF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Kobayashi Pharmaceutical Co., Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Kobayashi Pharmaceutical Co., Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Kobayashi Pharmaceutical Co., Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
KBYPF revenue · 4 questionsKBYPF's trailing twelve-month (TTM) revenue is $168B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · Kobayashi Pharmaceutical Co., Ltd. SEC filings · GAAP · Kobayashi Pharmaceutical Co., Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026